Skip to main content
Explore URMC
menu
Case Study: A Single Drug for Multiple Allergies

Case Study: A Single Drug for Multiple Allergies

It can be difficult to treat people with multiple allergic conditions, because drugs are usually tested against a single disease at a time. A recent case study highlights how the drug dupilumab drastically improved symptoms of multiple allergic diseases and quality of life for a young boy.

UR CTSI Researchers Suggest Vaping Could Cloud Your Thoughts

UR CTSI Researchers Suggest Vaping Could Cloud Your Thoughts

UR CTSI researchers have uncovered the first evidence of an association between vaping and mental fog in people.

Region Pioneers Use of Electronic Medical Records for Community Wellness and Health Equity

Region Pioneers Use of Electronic Medical Records for Community Wellness and Health Equity

An unusual collaboration among three regional data teams, including the UR CTSI, has cut through legal and technical challenges to leverage electronic medical records for population health reporting in the recently-released Community Health Indicators report.

UR CTSI Researchers Find Nationwide Links Between Vaping and COVID-19

UR CTSI Researchers Find Nationwide Links Between Vaping and COVID-19

Analyzing population data from the Centers for Disease Control and Prevention, UR CTSI Biostatistician Dongmei Li, Ph.D., found that states with more vapers had larger numbers of daily coronavirus cases and deaths in the early weeks of the pandemic.

UR CTSI Pilot Study Identifies Memory “Fingerprints”

UR CTSI Pilot Study Identifies Memory “Fingerprints”

UR CTSI-supported researchers are the first to observe and quantify the differences between how people reimagine common scenarios. These unique neurological “fingerprints” could ultimately be used to understand, study and even improve the treatment of disorders such as Alzheimer’s disease.